首页> 外文期刊>Cancer letters >A ROS-mediated lysosomal-mitochondrial pathway is induced by a novel Amonafide analogue, 7c, in human Hela cervix carcinoma cells
【24h】

A ROS-mediated lysosomal-mitochondrial pathway is induced by a novel Amonafide analogue, 7c, in human Hela cervix carcinoma cells

机译:新型Amonafide类似物7c在人Hela宫颈癌细胞中诱导ROS介导的溶酶体-线粒体途径

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, a novel naphthalimide derivative 7c was designed which is topo II inhibiting though owning weak DNA binders. It was shown that 7c could induce cancer cells apoptosis and have less cytotoxicity in normal human cell. Further investigations on Hela cells revealed that 7c could also induce ROS generation, lysosome rupture as well as cathepsin B release. Subsequent mitochondrial damages including mitochondrial membrane permeabilization and the release of cytochrome c were also found in 7c when treating with Hela cells. According to our data, 7c may act as a lead compound for potential anticancer drugs. The idea of naphthalimides modification may also provide a novel strategy for naphthalimides design.
机译:在这项研究中,设计了一种新颖的萘二甲酰亚胺衍生物7c,尽管它具有弱的DNA结合剂,但它对topo II具有抑制作用。结果表明7c可以诱导癌细胞凋亡,对正常人细胞的细胞毒性较小。对Hela细胞的进一步研究表明7c还可以诱导ROS产生,溶酶体破裂以及组织蛋白酶B释放。用Hela细胞处理后,在7c中还发现了随后的线粒体损伤,包括线粒体膜通透性和细胞色素c的释放。根据我们的数据,7c可能充当潜在抗癌药物的先导化合物。萘二甲酰亚胺改性的想法也可以为萘二甲酰亚胺设计提供新颖的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号